Astrazeneca Dividends - AZN

[ADVERT]

Best deals to access real time data!
Level 2 Basic Monthly Subscription for only ~~£62.08~~
Silver Monthly Subscription for only ~~£17.37~~
UK/US Silver Monthly Subscription for only £30.59
VAT not included

Stock Name	Stock Symbol	Market	Stock Type
Astrazeneca Plc	AZN	London	Ordinary Share

	Price Change	Price Change %	Stock Price	Last Trade
	177.00	2.04%	8,845.00	16:35:14

Open Price	Low Price	High Price	Close Price	Previous Close
8,900.00	8,828.00	8,982.00	8,845.00	8,668.00

more quote information »

Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Astrazeneca AZN Dividends History

Announcement Date	Type	Currency	Dividend Amount	Period Start	Period End	Ex Date	Record Date	Payment Date	Total Dividend Amount
29/07/2021	Interim	USX	90	31/12/2020	31/12/2021	12/08/2021	13/08/2021	13/09/2021	0
16/02/2021	Interim	USX	190	31/12/2019	31/12/2020	25/02/2021	26/02/2021	29/03/2021	280
30/07/2020	Interim	USX	90	31/12/2019	31/12/2020	13/08/2020	14/08/2020	14/09/2020	0
14/02/2020	Interim	USX	190	31/12/2018	31/12/2019	27/02/2020	28/02/2020	30/03/2020	280
25/07/2019	Interim	USX	90	31/12/2018	31/12/2019	08/08/2019	09/08/2019	09/09/2019	0
14/02/2019	Final	USX	190	31/12/2017	31/12/2018	28/02/2019	01/03/2019	27/03/2019	280
26/07/2018	Interim	USX	90	31/12/2017	31/12/2018	09/08/2018	10/08/2018	10/09/2018	0
02/02/2018	Final	USX	190	31/12/2016	31/12/2017	15/02/2018	16/02/2018	19/03/2018	280
27/07/2017	Interim	USX	90	31/12/2016	31/12/2017	10/08/2017	11/08/2017	11/09/2017	0
02/02/2017	Final	USX	190	31/12/2015	31/12/2016	16/02/2017	17/02/2017	20/03/2017	280
28/07/2016	Interim	USX	90	31/12/2015	31/12/2016	11/08/2016	12/08/2016	12/09/2016	0
04/02/2016	Final	USX	190	31/12/2014	31/12/2015	18/02/2016	19/02/2016	21/03/2016	280
30/07/2015	Interim	USX	90	31/12/2014	31/12/2015	13/08/2015	14/08/2015	14/09/2015	0
05/02/2015	Final	USX	190	31/12/2013	31/12/2014	19/02/2015	20/02/2015	23/03/2015	280
31/07/2014	Interim	USX	90	31/12/2013	31/12/2014	13/08/2014	15/08/2014	15/09/2014	0
06/02/2014	Final	USX	190	31/12/2012	31/12/2013	19/02/2014	21/02/2014	24/03/2014	280
01/08/2013	Interim	USX	90	31/12/2012	31/12/2013	14/08/2013	16/08/2013	16/09/2013	0
31/01/2013	Final	USX	190	31/12/2011	31/12/2012	13/02/2013	15/02/2013	18/03/2013	280
26/07/2012	Interim	USX	90	31/12/2011	31/12/2012	08/08/2012	10/08/2012	10/09/2012	0
02/02/2012	Final	USX	195	31/12/2010	31/12/2011	15/02/2012	17/02/2012	19/03/2012	280
28/07/2011	Interim	USX	85	31/12/2010	31/12/2011	03/08/2011	05/08/2011	12/09/2011	0
27/01/2011	Final	USX	185	31/12/2009	31/12/2010	02/02/2011	04/02/2011	14/03/2011	255
29/07/2010	Interim	USX	70	31/12/2009	31/12/2010	02/08/2010	04/08/2010	13/09/2010	0
28/01/2010	Final	USX	171	31/12/2008	31/12/2009	03/02/2010	05/02/2010	15/03/2010	230
30/07/2009	Interim	USX	59	30/12/2008	30/06/2009	05/08/2009	07/08/2009	14/09/2009	0
29/01/2009	Final	USX	150	31/12/2007	31/12/2008	04/02/2009	06/02/2009	16/03/2009	205
31/07/2008	Interim	USX	55	30/12/2007	30/06/2008	08/08/2008	06/08/2008	15/09/2008	0
31/01/2008	Final	USX	135	31/12/2006	31/12/2007	06/02/2008	08/02/2008	17/03/2008	187
26/07/2007	Interim	USX	52	30/06/2006	30/06/2007	08/08/2007	10/08/2007	17/09/2007	0
01/02/2007	Final	USX	123	31/12/2005	31/12/2006	07/02/2007	09/02/2007	19/03/2007	172
27/07/2006	Interim	USX	49	30/12/2005	30/06/2006	09/08/2006	11/08/2006	18/09/2006	0
01/02/2006	Final	USX	92	31/12/2004	31/12/2005	08/02/2006	10/02/2006	20/03/2006	130
29/07/2005	Interim	USX	38	30/12/2004	30/06/2005	10/08/2005	12/08/2005	19/09/2005	0
27/01/2005	Final	USX	64.5	31/12/2003	31/12/2004	09/02/2005	11/02/2005	21/03/2005	94
22/07/2004	Interim	USX	29.5	30/12/2003	30/06/2004	11/08/2004	13/08/2004	20/09/2004	0
29/01/2004	Final	USX	54	31/12/2002	31/12/2003	18/02/2004	20/02/2004	06/04/2004	79.5
24/07/2003	Interim	USX	25.5	30/12/2002	30/06/2003	20/08/2003	22/08/2003	06/10/2003	0
30/01/2003	Final	USX	47	31/12/2001	31/12/2002	19/02/2003	21/02/2003	07/04/2003	70
25/07/2002	Interim	USX	23	30/12/2001	30/06/2002	21/08/2002	23/08/2002	07/10/2002	0
31/01/2002	Final	USX	47	31/12/2000	31/12/2001	20/02/2002	22/02/2002	08/04/2002	70
26/07/2001	Interim	USX	23	30/12/2000	30/06/2001	22/08/2001	24/08/2001	05/10/2001	0
08/02/2001	Final	USX	47	31/12/1999	31/12/2000	21/02/2001	23/02/2001	09/04/2001	70
01/08/2000	Interim	USX	23	30/12/1999	30/06/2000	04/09/2000	08/09/2000	23/10/2000	0
24/02/2000	Final	USX	47	31/12/1998	31/12/1999	06/03/2000	10/03/2000	17/04/2000	70
03/08/1999	Interim	USX	23	30/12/1998	30/06/1999	06/09/1999	10/09/1999	25/10/1999	0

Top Dividend Posts

Date	Subject
21/9/2021 08:16	arja: seems to be holding AZN back today so far as I was expecting it to kick on a bit ! Read Full Thread Follow Reply
20/9/2021 16:15	hotfinance14: This should close over £5 up as it is masskve news for AZN. Read Full Thread Follow Reply
20/9/2021 15:19	philanderer: AZN best one of my lot by a mile today. Read Full Thread Follow Reply
19/9/2021 11:31	riskonricky: I admire your enthusiasm, but based on what? The whole her2 inhibitor market is $5-6Billion. AZN is a £125 billon company. How on earth would this news make it rocket? And where would it rocket to? Read Full Thread Follow Reply
14/9/2021 12:42	umitw: I wonder why sajid decided to have Moderna & Pfizer as a bossier not AZN..? Read Full Thread Follow Reply
10/9/2021 11:41	hjs: AZN has gone down as a result of their "Vaccine Booster" statement. Market will always react to any news to mark the share price up or down! this is my view. Read Full Thread Follow Reply
03/9/2021 15:42	stutes: Today's deal with EU shows to me AZN sorted the mess out but the company itself needs to address the reasons why it messed up. Read Full Thread Follow Reply
07/8/2021 09:22	gibbs1: August/12/2021 Ex-dividend day for interim dividend Read Full Thread Follow Reply
01/8/2021 09:09	waldron: CAMBRIDGE, Britain (AP) _ Astrazeneca PLC (AZN) on Thursday reported second-quarter profit of $550 million. The Cambridge, Britain-based company said it had profit of 21 cents per share. Earnings, adjusted for non-recurring costs, came to 45 cents per share. The pharmaceutical posted revenue of $8.22 billion in the period. Astrazeneca shares have increased 14% since the beginning of the year. The stock has climbed almost 1% in the last 12 months. This story was generated by Automated Insights (Http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AZN at Https://www.zacks.com/ap/AZN Read Full Thread Follow Reply
26/5/2021 09:49	beckers2008: N100, More like, AZN will confront and prove that the contract the EU signed was 'best efforts' as AZN were contractually committed to the UK. Now it has gone to court, AZN can show what a shambles the EU procurement process is. The EU will not come out of this in a good light, that is assured! Read Full Thread Follow Reply

Advertise Here

Your Recent History

LSE

AZN

Astrazenec..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US

P: V: D:20210925 19:02:27